Variant report
Variant | esv3443437 |
---|---|
Chromosome Location | chr12:106920534-106948432 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537733634 | chr12:106920651-106920652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557337990 | chr12:106920665-106920666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142489027 | chr12:106920698-106920699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144935075 | chr12:106920719-106920720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536207225 | chr12:106920732-106920733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553515994 | chr12:106920748-106920749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183238045 | chr12:106920781-106920782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78062315 | chr12:106920784-106920785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147954450 | chr12:106920830-106920831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575481461 | chr12:106920833-106920834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187355496 | chr12:106920858-106920859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116731056 | chr12:106920948-106920949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368011660 | chr12:106921066-106921067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546237804 | chr12:106921079-106921080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372193541 | chr12:106921095-106921096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141176546 | chr12:106921124-106921125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551593011 | chr12:106921143-106921144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571522513 | chr12:106921152-106921153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563990968 | chr12:106921163-106921164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570443594 | chr12:106921183-106921184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201289085 | chr12:106921189-106921190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143434828 | chr12:106921198-106921199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537221280 | chr12:106921205-106921206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148017208 | chr12:106921207-106921208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11113027 | chr12:106921221-106921222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs536693596 | chr12:106921276-106921277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374613526 | chr12:106921301-106921302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573399374 | chr12:106921331-106921332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192259518 | chr12:106921344-106921345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565912088 | chr12:106921348-106921349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367878241 | chr12:106921349-106921350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115289548 | chr12:106921355-106921356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575416224 | chr12:106921358-106921359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544028521 | chr12:106921370-106921371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184681033 | chr12:106921378-106921379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574635224 | chr12:106921405-106921406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112011825 | chr12:106921453-106921454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559702018 | chr12:106921467-106921468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150107531 | chr12:106921481-106921482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12579583 | chr12:106921489-106921490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs562398580 | chr12:106921516-106921517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377239140 | chr12:106921525-106921526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568256254 | chr12:106921538-106921539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531146310 | chr12:106921552-106921553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550887525 | chr12:106921554-106921555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs58450022 | chr12:106921559-106921560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs398076941 | chr12:106921562-106921563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs397693922 | chr12:106921563-106921564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200147151 | chr12:106921564-106921565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565956735 | chr12:106921575-106921576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 16751803 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:106920600-106921800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr12:106920800-106921400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr12:106920800-106921600 | Enhancers | HUVEC | blood vessel |
4 | chr12:106921000-106921400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr12:106921000-106921600 | Enhancers | NH-A | brain |
6 | chr12:106921200-106921600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr12:106929400-106929600 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr12:106933800-106934600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:106934600-106935000 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr12:106934800-106935000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr12:106943200-106943800 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
12 | chr12:106943800-106948800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
13 | chr12:106944800-106947200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr12:106945200-106945400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr12:106945200-106945600 | Active TSS | HepG2 | liver |
16 | chr12:106945400-106945600 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr12:106945400-106945800 | Enhancers | K562 | blood |
18 | chr12:106945400-106946400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |